Pharmaceuticals News

Uppsala, Sweden, 2013-06-07 08:59 CEST (GLOBE NEWSWIRE) --   Year-end report for the fiscal year May 2012 - April 2013  €   CONTINUED EXPANSION OF THE PRODUCT CANDIDATE...

Uppsala, Sweden, 2013-06-07 08:59 CEST (GLOBE NEWSWIRE) --   Bokslutskommuniké för räkenskapsåret maj 2012 - april 2013   FORTSATT EXPANSION AV PRODUKTKANDIDATPORTFÖLJEN OCH...

Valneva SE announces the sale of its Clinical Manufacturing Operations (CMO) in France to Biological E Next step in broadening an excellent strategic partnership Lyon (France), Hyderabad (India)...

Valneva SE annonce la cession de son activité française de bioproduction à la société Biological E Cet accord vient renforcer l'excellent partenariat stratégique existant entre les deux sociétés ...

AB Sanitas (toliau – Bendrovė) informuoja, kad 2013 m. birželio 6 d. Vilniaus miesto apylinkės teismas priėmė sprendimą byloje pagal pareiškėjo Bendrovės akcininko Valeant Pharmaceuticals...

AB Sanitas (hereinafter, the “Company”) hereby informs that on 6 June 2013 the Vilnius City Local Court adopted a judgement in the case according to the claim of the Company’s shareholder Valeant...

CAMBRIDGE, Mass., June 6, 2013 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that William Sullivan, CFO, is scheduled to present at the Goldman Sachs 34th Annual...

TORONTO, ONTARIO--(Marketwired - June 6, 2013) - Arch Biopartners Inc (Arch) or (the Company) (CNSX:ACH) (OTCBB:FOIFF) announced today that the U.S. Patent and Trademark Office has issued...

SANDY, Utah, June 6, 2013 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (the "Company") (Pink Sheets:RAFA) announces commencement of production of the antibiotic Ceftriaxone. Ceftriaxone treats...

NEW CASTLE, Del., June 6, 2013 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has prepaid the...